We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Advanced Medical Solutions Group plc (AMS) Ordinary 5p

Sell:188.80p Buy:191.80p 0 Change: No change
FTSE AIM 100:0.02%
Market closed |  Prices as at close on 25 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:188.80p
Buy:191.80p
Change: No change
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
Market closed |  Prices as at close on 25 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:188.80p
Buy:191.80p
Change: No change
Market closed |  Prices as at close on 25 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Advanced Medical Solutions Group plc is a United Kingdom-based company that specializes in the design, development, manufacture and distribution of novel tissue-healing technologies, including advanced wound care products, surgical dressings and medical grade materials, as well as medical adhesives and sutures for closing and sealing tissue. The Company manufactures a range of products and materials that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats. It operates through two divisions for its sales, marketing and research and development (R&D) activities, including Surgical and Woundcare. Its surgical business unit is focused on selling and marketing its branded products and are sold directly and through distributors. Its Woundcare business unit is focused on distribution and marketing its products that are supplied to medical device partners under their own brands. The Company offers its products under ActivHeal, LiquiBand and RESORBA.

Contact details

Address:
Premier Park, 33 Road One
WINSFORD
CW7 3RT
United Kingdom
Telephone:
+44 (01606) 863500
Website:
https://www.admedsol.com/

Important dates

Future events
Final dividend payment date 21 June 2024 21/06/24
Final ex-dividend date 30 May 2024 30/05/24
Past events
Final results 13 March 2024 13/03/24
Trading Announcement 10 January 2024 10/01/24
Interim dividend payment date 27 October 2023 27/10/23
Interim ex-dividend date 28 September 2023 28/09/23
Interim results 20 September 2023 20/09/23
Trading Announcement 04 September 2023 04/09/23
Trading Announcement 11 July 2023 11/07/23
Final dividend payment date 09 June 2023 09/06/23
AGM 31 May 2023 31/05/23
Final ex-dividend date 18 May 2023 18/05/23
Annual report 26 April 2023 26/04/23

General stock information

EPIC:
AMS
ISIN:
GB0004536594
Market cap:
£417.73 million
Shares in issue:
217.34 million
Sector:
Health Care Equipment & Services
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
FTSE AIM 100,FTSE AIM All Share

Key personnel

  • Andrew Meredith
    Chief Executive Officer, Executive Director
  • Eddie Johnson
    Chief Financial Officer, Executive Director
  • Brian Dowd
    Vice President - Corporate Business Development
  • Cathy Tomlinson
    Group Human Resources Director
  • Simon Coates
    IT Director
  • Andy Donnelly
    Group R&D Director
  • Rose Guang
    Group Quality Assurance/Regulatory Affairs (QA/RA) Director
  • Ross McDonald
    Business Unit Director - Surgical
  • Becky Walmsley
    Business Unit Director - Woundcare
  • Owen Bromley
    Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.
Deal now Deal for just £11.95 per trade in a Stocks and Shares ISA, Lifetime ISA , SIPP or Fund and Share Account
Deal now

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.